Karyopharm Therapeutics Inc 's

• KPTI's Stock Performance relative to its Competitors

Astrazeneca Plc Share Performance +1.32% One Year

Astrazeneca Plc Profile AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks. More about Astrazeneca Plc's Market Share

Iovance Biotherapeutics inc Share Performance +20.85% 30 Days

Iovance Biotherapeutics inc Profile Iovance Biotherapeutics Inc operates on a business model centered around developing and commercializing novel cancer immunotherapy treatments. The company focuses on utilizing its proprietary Tumor Infiltrating Lymphocyte (TIL) therapy, which involves collecting and expanding a patient's own immune cells to target and kill cancer cells. Iovance primarily seeks to advance its TIL therapy candidates through clinical trials and collaborations while aiming to provide effective and personalized treatment options for cancer patients. More about Iovance Biotherapeutics inc 's Market Share

Incyte Corporation Share Performance +20.77% This Year

Incyte Corporation Profile Incyte Corporation is a biopharmaceutical company that primarily focuses on the research, development, and commercialization of innovative medicines targeting oncology and serious inflammatory conditions. Their business model emphasizes robust R&D investments to discover potential drug candidates, often engaging in collaborations with other organizations to enhance their development capabilities. Incyte leverages its extensive intellectual property portfolio to protect and maximize the value of its therapeutic advancements in the market. More about Incyte Corporation's Market Share

Immix Biopharma Inc Share Performance -11.28% Over The Past 5 Days

Immix Biopharma Inc Profile ImmIx Biopharma Inc is a biotechnology company that focuses on developing novel therapeutics for the treatment of cancer. Their business model involves conducting extensive research and development to discover and optimize drug candidates, followed by preclinical and clinical testing to assess their safety and effectiveness. They aim to collaborate with pharmaceutical companies or seek licensing agreements to further develop and commercialize their biopharmaceutical products. More about Immix Biopharma Inc 's Market Share

Werewolf Therapeutics Inc Share Performance +3.44% Over The Past 5 Days

Werewolf Therapeutics Inc Profile Werewolf Therapeutics Inc operates with a business model focused on utilizing innovative technologies to develop therapies targeting cancer using immune cell activation. More about Werewolf Therapeutics Inc 's Market Share

Sources: Karyopharm Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, September 14, 2026 4:00 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Karyopharm Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.